{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:13:16Z","timestamp":1771575196701,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00417-025-07023-0","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:20:03Z","timestamp":1762762803000},"page":"557-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the efficacy and clinical applications of three different myopia control methods: repeated low-level red light, 1% atropine, and orthokeratology lenses in children and adolescent"],"prefix":"10.1007","volume":"264","author":[{"given":"Yun-yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben-Chu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-1298","authenticated-orcid":false,"given":"Fu-Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-8915","authenticated-orcid":false,"given":"Duo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"4","key":"7023_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3760\/j.issn.0253-9624.2017.04.004","volume":"51","author":"D YanHui","year":"2017","unstructured":"YanHui D (2017) A study on the global prevalence and trend of myopia and high myopia from 2000 to 2050. Chin J Prev Med 51(4):1. https:\/\/doi.org\/10.3760\/j.issn.0253-9624.2017.04.004","journal-title":"Chin J Prev Med"},{"issue":"5","key":"7023_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA et al (2016) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123(5):1036\u201342. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006","journal-title":"Ophthalmology"},{"issue":"10","key":"7023_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3760\/cma.j.issn.0412-4081.2019.10.001","volume":"55","author":"X Xu","year":"2019","unstructured":"Xu X, He XG (2019) Strengthening the Understanding of the pathological evolution of myopia. Zhonghua Yan Ke Za Zhi 55(10):721\u2013725. https:\/\/doi.org\/10.3760\/cma.j.issn.0412-4081.2019.10.001. (Chinese)","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"2","key":"7023_CR4","doi-asserted-by":"publisher","first-page":"CD014758","DOI":"10.1002\/14651858.CD014758.pub2","volume":"2","author":"JG Lawrenson","year":"2023","unstructured":"Lawrenson JG, Shah R, Huntjens B et al (2023) Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev 2(2):CD014758. https:\/\/doi.org\/10.1002\/14651858.CD014758.pub2. (Update in: Cochrane Database Syst Rev. 2025 Feb 13;2:CD014758. doi: 10.1002\/14651858.CD014758.pub3)","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"7023_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/jop.2017.0144","volume":"34","author":"HDM Tran","year":"2018","unstructured":"Tran HDM, Tran YH, Tran TD et al (2018) A review of myopia control with atropine. J Ocul Pharmacol Ther 34(5):374\u20139. https:\/\/doi.org\/10.1089\/jop.2017.0144","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"7023_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clae.2021.02.003","volume":"44","author":"SJ Vincent","year":"2021","unstructured":"Vincent SJ, Cho P, Chan KY et al (2021) CLEAR - Orthokeratology. Cont Lens Anterior Eye 44(2):240\u2013269. https:\/\/doi.org\/10.1016\/j.clae.2021.02.003","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"7023_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ophtha.2018.11.026","volume":"126","author":"DK VanderVeen","year":"2019","unstructured":"VanderVeen DK, Kraker RT, Pineles SL et al (2019) Use of orthokeratology for the prevention of myopic progression in children: a report by the American academy of ophthalmology. Ophthalmology 126(4):623\u201336. https:\/\/doi.org\/10.1016\/j.ophtha.2018.11.026","journal-title":"Ophthalmology"},{"issue":"4","key":"7023_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9612","volume":"6","author":"X He","year":"2023","unstructured":"He X, Wang J, Zhu Z et al (2023) Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial. JAMA Netw Open 6(4):e239612. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.9612","journal-title":"JAMA Netw Open"},{"issue":"2","key":"7023_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s40123-023-00671-7","volume":"12","author":"W Wang","year":"2023","unstructured":"Wang W, Jiang Y, Zhu Z et al (2023) Axial shortening in myopic children after repeated low-level red-light therapy: post hoc analysis of a randomized trial. Ophthalmol Ther 12(2):1223\u201337. https:\/\/doi.org\/10.1007\/s40123-023-00671-7","journal-title":"Ophthalmol Ther"},{"key":"7023_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ajo.2023.03.036","volume":"252","author":"J Tang","year":"2023","unstructured":"Tang J, Liao Y, Yan N et al (2023) Efficacy of repeated Low-Level Red-Light therapy for slowing the progression of childhood myopia: A systematic review and Meta-analysis. Am J Ophthalmol 252:153\u2013163. https:\/\/doi.org\/10.1016\/j.ajo.2023.03.036","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"7023_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/opo.12939","volume":"42","author":"L Zhou","year":"2022","unstructured":"Zhou L, Xing C, Qiang W, Hua C, Tong L (2022) Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort. Ophthalmic Physiol Opt 42(2):335\u2013344. https:\/\/doi.org\/10.1111\/opo.12939","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"7023_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10439-011-0454-7","volume":"40","author":"H Chung","year":"2012","unstructured":"Chung H, Dai T, Sharma SK et al (2012) The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng 40(2):516\u2013533. https:\/\/doi.org\/10.1007\/s10439-011-0454-7","journal-title":"Ann Biomed Eng"},{"issue":"6","key":"7023_CR13","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s40123-022-00585-w","volume":"11","author":"L Tian","year":"2022","unstructured":"Tian L, Cao K, Ma DL et al (2022) Investigation of the efficacy and safety of 650 Nm low-level red light for myopia control in children: a randomized controlled trial. Ophthalmol Ther 11(6):2259\u20132270. https:\/\/doi.org\/10.1007\/s40123-022-00585-w","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"7023_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40123-023-00875-x","volume":"13","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun Z, Du B et al (2024) The effects of repeated low-level red-light therapy on the structure and vasculature of the choroid and retina in children with premyopia. Ophthalmol Ther 13(3):739\u2013759. https:\/\/doi.org\/10.1007\/s40123-023-00875-x","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"7023_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","volume":"130","author":"J Dong","year":"2023","unstructured":"Dong J, Zhu Z, Xu H et al (2023) Myopia control effect of repeated low-level red-light therapy in chinese children: a randomized, double-blind, controlled clinical trial. Ophthalmology 130(2):198\u2013204. https:\/\/doi.org\/10.1016\/j.ophtha.2022.08.024","journal-title":"Ophthalmology"},{"issue":"1","key":"7023_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ophtha.2023.08.020","volume":"131","author":"W Zhou","year":"2024","unstructured":"Zhou W, Liao Y, Wang W et al (2024) Efficacy of different powers of Low-Level red light in children for myopia control. Ophthalmology 131(1):48\u201357. https:\/\/doi.org\/10.1016\/j.ophtha.2023.08.020","journal-title":"Ophthalmology"},{"issue":"10","key":"7023_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijms.85746","volume":"20","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Cao X, Zhang Y, Zhou Y, Zhang J, Zhang X, Zhu Y, Xue L (2023) Repeated low-level red-light therapy for controlling onset and progression of myopia-a review. Int J Med Sci 20(10):1363\u20131376. https:\/\/doi.org\/10.7150\/ijms.85746","journal-title":"Int J Med Sci"},{"issue":"3","key":"7023_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","volume":"46","author":"A Upadhyay","year":"2020","unstructured":"Upadhyay A, Beuerman RW (2020) Biological mechanisms of Atropine control of myopia. Eye Contact Lens 46(3):129\u201335. https:\/\/doi.org\/10.1097\/ICL.0000000000000677","journal-title":"Eye Contact Lens"},{"issue":"6","key":"7023_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/APO.0000000000000232","volume":"5","author":"D Tan","year":"2016","unstructured":"Tan D, Tay SA, Loh KL et al (2016) Topical atropine in the control of myopia. Asia-Pac J Ophthalmol 5(6):424\u20138. https:\/\/doi.org\/10.1097\/APO.0000000000000232","journal-title":"Asia-Pac J Ophthalmol"},{"issue":"3","key":"7023_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/opo.12052","volume":"33","author":"NA McBrien","year":"2013","unstructured":"McBrien NA, Stell WK, Carr B (2013) How does atropine exert its anti-myopia effects? Ophthalmic Physiol Opt 33(3):373\u201378. https:\/\/doi.org\/10.1111\/opo.12052","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"7023_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7150\/ijms.39365","volume":"17","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Tang Y, Guo L et al (2020) Efficacy and safety of 1% atropine on retardation of moderate myopia progression in Chinese school children. Int J Med Sci 17(2):176\u2013181. https:\/\/doi.org\/10.7150\/ijms.39365","journal-title":"Int J Med Sci"},{"issue":"4","key":"7023_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jaapos.2016.03.005","volume":"20","author":"Q Gong","year":"2016","unstructured":"Gong Q, Liu L (2016) Therapeutic effect of atropine 1% in children with low myopia. J AAPOS 20(4):379. https:\/\/doi.org\/10.1016\/j.jaapos.2016.03.005","journal-title":"J AAPOS"},{"issue":"5","key":"7023_CR23","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/02713683.2015.1050743","volume":"41","author":"SM Li","year":"2016","unstructured":"Li SM, Kang MT, Wu SS et al (2016) Efficacy, safety and acceptability of orthokeratology on slowing axial elongation in myopic children by meta-analysis. Curr Eye Res 41(5):600\u2013608. https:\/\/doi.org\/10.3109\/02713683.2015.1050743","journal-title":"Curr Eye Res"},{"issue":"3","key":"7023_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/OPX.0000000000000505","volume":"92","author":"JK Si","year":"2015","unstructured":"Si JK, Tang K, Bi HS, Guo DD, Guo JG, Wang XR (2015) Orthokeratology for myopia control: a meta-analysis. Optom Vis Sci 92(3):252\u20137. https:\/\/doi.org\/10.1097\/OPX.0000000000000505","journal-title":"Optom Vis Sci"},{"key":"7023_CR25","unstructured":"Yang Y (2024) Orthokeratology for high myopia (OHM)[J]"},{"issue":"5","key":"7023_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/ICL.0000000000000516","volume":"44","author":"J Jun","year":"2018","unstructured":"Jun J, Zhiwen B, Feifu W et al (2018) Level of compliance in orthokeratology. Eye Contact Lens 44(5):330\u201334. https:\/\/doi.org\/10.1097\/ICL.0000000000000516","journal-title":"Eye Contact Lens"},{"issue":"12","key":"7023_CR27","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.jfma.2022.05.005","volume":"121","author":"HR Tsai","year":"2022","unstructured":"Tsai HR, Wang JH, Huang HK et al (2022) Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: a systematic review and network meta-analysis. J Formos Med Assoc 121(12):2490\u20132500. https:\/\/doi.org\/10.1016\/j.jfma.2022.05.005","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"7023_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8915867","volume":"2021","author":"F Xiong","year":"2021","unstructured":"Xiong F, Mao T, Liao H et al (2021) Orthokeratology and low-intensity laser therapy for slowing the progression of myopia in children. BioMed Res Int 2021(1):8915867. https:\/\/doi.org\/10.1155\/2021\/8915867","journal-title":"BioMed Res Int"},{"issue":"2","key":"7023_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00417-022-05794-4","volume":"261","author":"H Chen","year":"2023","unstructured":"Chen H, Wang W, Liao Y et al (2023) Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol 261(2):575\u2013584. https:\/\/doi.org\/10.1007\/s00417-022-05794-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7023_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0302-5","volume":"16","author":"M He","year":"2016","unstructured":"He M, Du Y, Liu Q et al (2016) Effects of orthokeratology on the progression of low to moderate myopia in Chinese children. BMC Ophthalmol 16:126. https:\/\/doi.org\/10.1186\/s12886-016-0302-5","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"7023_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.14166\/j.iSSN.1671-2420.2022.03.017","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang Y, Xingtao XZhou, Chen Z et al (2022) Observation of corneal morphological changes and epithelial and stromal redistribution after orthokeratology lens discontinuation for 1 month [J]. Chin J Eye Otolaryngol 22(3):300\u2013303. https:\/\/doi.org\/10.14166\/j.iSSN.1671-2420.2022.03.017","journal-title":"Chin J Eye Otolaryngol"},{"issue":"3","key":"7023_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ophtha.2022.10.002","volume":"130","author":"R Xiong","year":"2023","unstructured":"Xiong R, Zhu Z, Jiang Y et al (2023) Longitudinal changes and predictive value of choroidal thickness for myopia control after repeated low-level red-light therapy. Ophthalmology 130(3):286\u2013296. https:\/\/doi.org\/10.1016\/j.ophtha.2022.10.002","journal-title":"Ophthalmology"},{"issue":"4","key":"7023_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.icl.0000140637.58027.9b","volume":"30","author":"PS Soni","year":"2004","unstructured":"Soni PS, Nguyen TT, Bonanno JA (2004) Overnight orthokeratology: refractive and corneal recovery after discontinuation of reverse-geometry lenses. Eye Contact Lens 30(4):254\u2013262. https:\/\/doi.org\/10.1097\/01.icl.0000140637.58027.9b","journal-title":"Eye Contact Lens"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07023-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:43:38Z","timestamp":1771573418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07023-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7023"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07023-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We are indebted to the participants who were involved in this trial, without whom the trial would not have been possible.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional ethics committee of Chongqing Aier Eye Hospital (202311005). The study was registered in the Chinese Clinical Trial Registry (ChiCTR2300078628). The study was conducted in accordance with the Declaration of Helsinki for study of human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}